News and Views
Nature Medicine 15, 841 - 842 (2009)
doi:10.1038/nm0809-841
Blocking and tackling HIV
Nancy L. Haigwood1 & Vanessa M. Hirsch2
- Nancy L. Haigwood is at the Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, USA
- Vanessa M. Hirsch is at the National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.
Correspondence to: Nancy L. Haigwood1 e-mail: haigwood@ohsu.edu
Abstract
Two studies suggest that low levels of antibodies, when present continuously, effectively limit or prevent HIV infection (pages 951–954 and 901–906). The findings provide hope for the development of a vaccine.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Is an HIV vaccine possible?Nature Medicine News and Views (01 Jun 1999)
HIV?1 neutralizing antibodies: How full is the bottle?Nature Medicine News and Views (01 Feb 1999)
See all 9 matches for News And ViewsRESEARCH
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaquesNature Medicine Letter (01 Aug 2009)
Fc receptor but not complement binding is important in antibody protection against HIVNature Letters to Editor (06 Sep 2007)
See all 33 matches for Research
